ARWR241220C18000
- 6.70
- 0.000.00%
Arrowhead Pharmaceuticals Newsroom
Express News | Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Sanofi (OtherSNYNF)
Arrowhead Pharmaceuticals Faces Distribution Risks With Vanscoy Reliance
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies
Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup
Express News | Arrowhead Pharmaceuticals Shares up 6.2% ; at Least Two Brokerages Raise PT After Licensing Deal With Sarepta
Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.
Express News | Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock
RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $42
Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $45
A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $26 to $45
Express News | Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target
Arrowhead Pharma Analyst Ratings
RBC Capital Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
Hold Rating on Arrowhead Pharmaceuticals: Balancing Strategic Advancements With Execution Risks
Express News | Arrowhead Pharmaceuticals : Citigroup Cuts Target Price to $26 From $27
Express News | Arrowhead Pharmaceuticals : Jefferies Raises Target Price to $67 From $65
Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ...
Arrowhead Pharmaceuticals Eyes Future Growth With Strategic Deals